Showing results (1781-1790 of 1,849) with videos related to

Sort By:
Pageof 185
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2019
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple MyelomaSam H Ahmedzai, John A Snowden, Andrew John Ashcroft, et al.
Emerging Infectious Diseases|February 28, 2022
Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018Jonathan W Ashcroft, Adebola Olayinka, Nnaemeka Ndodo, et al.
Nature Communications|January 13, 2019
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretionElisa Vergari, Jakob G Knudsen, Reshma Ramracheya, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2022
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task forceShirley V Wang, Anton Pottegård, William Crown, et al.
Nature Metabolism|September 23, 2024
Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetesThomas G Hill, Rui Gao, Anna Benrick, et al.
BMJ Open|September 12, 2025
Randomised controlled trial to measure effectiveness and cost-effectiveness of a digital social intervention promoted by primary care clinicians to adults with asthma to improve asthma control: protocolGeorgios Dimitrios Karampatakis, Helen E Wood, Chris J Griffiths, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2022
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task ForceShirley V Wang, Anton Pottegård, William Crown, et al.
Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Pageof 185